Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12611001198910Phase 2Not yet recruiting
Phase 2, open-label trial of bisoprolol, formoterol, testosterone, oestradiol, somatropin and 1 more in obesity, Hypogonadism and growth hormone deficiency (GHD), sponsored by National Health and Medical Research Council. Planned start Feb 2012; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12611001198910.